Rakovina Therapeutics Inc. (TSXV:RKV)
Canada
· Delayed Price · Currency is CAD 0.110
0.00 (0.00%)
At close: Apr 28, 2026
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of CAD 2.33 million as of April 29, 2026. Its market cap has decreased by -82.61% in one year.
Market Cap
2.33M
Enterprise Value
4.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 14.88M to 2.33M, a decrease of -84.36%. That is a compound annual growth rate of -30.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.33M | 10.00% |
| Dec 31, 2025 | 2.11M | -92.08% |
| Dec 31, 2024 | 26.69M | 348.09% |
| Dec 29, 2023 | 5.96M | -52.61% |
| Dec 29, 2022 | 12.57M | -18.16% |
| Dec 31, 2021 | 15.36M | 3.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Appili Therapeutics | 2.65M |
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 3.45M |
| Universal Ibogaine | 1.56M |
| Entheon Biomedical | 1.39M |
| Cytophage Technologies | 4.40M |
| Vaxil Bio | 1.16M |
| Restart Life Sciences | 4.75M |